Necrobiosis Lipoidica: Disease Pathogenesis & Treatment

The presentation discusses Necrobiosis Lipoidica (NL), a chronic inflammatory skin disease often associated with diabetes and characterized by lipidized plaques and ulcerations, primarily on the lower legs. It highlights the disease's pathogenesis, which is linked to TH-1 driven immune responses involving interferon gamma, and details the common demographic of affected patients, typically middle-aged and often obese, with a notable prevalence of poorly controlled diabetes. The speaker emphasizes the importance of managing diabetes to alleviate symptoms and complications of NL. Treatment strategies include topical corticosteroids, calcineurin inhibitors, systemic therapies like TNF-alpha inhibitors and Jack inhibitors, with recent trial data suggesting efficacy for Jack 1-2 inhibitors. The discussion includes results from a trial showing significant improvement in patients treated with these medications, as well as ongoing research on the molecular mechanisms and potential overlapping pathways that could be targeted therapeutically. The findings underline the critical role of interferon gamma and genetic regulation in NL's pathology, suggesting future exploration of targeted therapies in clinical trials.